BUVIDAL Depot sol inj 128 mg/0.36ml ser pré
7680679410145
CH-67941
N07BC01
01.01.3.
Reimbursement limitations:
BUVIDAL
Conformément à l’annexe 1 de l’OPAS (RS 832.112.31), cf. chapitre 8, Psychiatrie et psychothérapie / …
1 / 3
google
Details
- Product number
- 6794107
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- buprenorphinum 128 mg, N-methylpyrrolidonum, phosphatidylcholinum ex soja, glyceroli dioleas, ad solutionem pro 0.36 ml.
Articles (1)
Buvidal 128 mg, Depot-Injektionslösung
Depot-Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
128.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 273.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Future Health Pharma GmbH
8620 Wetzikon ZH
Authorization information
- Swissmedic authorization number
- 67941
- Drug name
- Buvidal, Depot-Injektionslösung
- Galenic form
- LSPA
- ATC Code
- N07BC01
- Authorization status
- Z
- Dispensation category
- A+
- First authorization
- 17/12/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BUVIDAL Depot sol inj 128 mg/0.36ml ser pré
- Description (DE)
- BUVIDAL Depot Inj Lös 128 mg/0.36ml Fertspr
- Market launch
- 17/12/2020
- Narcotic (BTM)
- A